Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Benjamin E. J., Plehn J. F., D'Agostino R. B., Belanger A. J., Comai K., Fuller D. L., Wolf P. A., Levy D. Mitral annular calcification and the risk of stroke in an elderly cohort. N Engl J Med. 1992 Aug 6;327(6):374–379. doi: 10.1056/NEJM199208063270602. [DOI] [PubMed] [Google Scholar]
- Brodsky M. A., Allen B. J., Capparelli E. V., Luckett C. R., Morton R., Henry W. L. Factors determining maintenance of sinus rhythm after chronic atrial fibrillation with left atrial dilatation. Am J Cardiol. 1989 May 1;63(15):1065–1068. doi: 10.1016/0002-9149(89)90079-9. [DOI] [PubMed] [Google Scholar]
- Cairns J. A., Connolly S. J. Nonrheumatic atrial fibrillation. Risk of stroke and role of antithrombotic therapy. Circulation. 1991 Aug;84(2):469–481. doi: 10.1161/01.cir.84.2.469. [DOI] [PubMed] [Google Scholar]
- Connolly S. J., Laupacis A., Gent M., Roberts R. S., Cairns J. A., Joyner C. Canadian Atrial Fibrillation Anticoagulation (CAFA) Study. J Am Coll Cardiol. 1991 Aug;18(2):349–355. doi: 10.1016/0735-1097(91)90585-w. [DOI] [PubMed] [Google Scholar]
- Dittrich H. C., Erickson J. S., Schneiderman T., Blacky A. R., Savides T., Nicod P. H. Echocardiographic and clinical predictors for outcome of elective cardioversion of atrial fibrillation. Am J Cardiol. 1989 Jan 15;63(3):193–197. doi: 10.1016/0002-9149(89)90284-1. [DOI] [PubMed] [Google Scholar]
- Ezekowitz M. D., Bridgers S. L., James K. E., Carliner N. H., Colling C. L., Gornick C. C., Krause-Steinrauf H., Kurtzke J. F., Nazarian S. M., Radford M. J. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators. N Engl J Med. 1992 Nov 12;327(20):1406–1412. doi: 10.1056/NEJM199211123272002. [DOI] [PubMed] [Google Scholar]
- Fatkin D., Kuchar D. L., Thorburn C. W., Feneley M. P. Transesophageal echocardiography before and during direct current cardioversion of atrial fibrillation: evidence for "atrial stunning" as a mechanism of thromboembolic complications. J Am Coll Cardiol. 1994 Feb;23(2):307–316. doi: 10.1016/0735-1097(94)90412-x. [DOI] [PubMed] [Google Scholar]
- Kopecky S. L., Gersh B. J., McGoon M. D., Whisnant J. P., Holmes D. R., Jr, Ilstrup D. M., Frye R. L. The natural history of lone atrial fibrillation. A population-based study over three decades. N Engl J Med. 1987 Sep 10;317(11):669–674. doi: 10.1056/NEJM198709103171104. [DOI] [PubMed] [Google Scholar]
- Manning W. J., Silverman D. I., Katz S. E., Riley M. F., Come P. C., Doherty R. M., Munson J. T., Douglas P. S. Impaired left atrial mechanical function after cardioversion: relation to the duration of atrial fibrillation. J Am Coll Cardiol. 1994 Jun;23(7):1535–1540. doi: 10.1016/0735-1097(94)90652-1. [DOI] [PubMed] [Google Scholar]
- Manning W. J., Silverman D. I., Keighley C. S., Oettgen P., Douglas P. S. Transesophageal echocardiographically facilitated early cardioversion from atrial fibrillation using short-term anticoagulation: final results of a prospective 4.5-year study. J Am Coll Cardiol. 1995 May;25(6):1354–1361. doi: 10.1016/0735-1097(94)00560-D. [DOI] [PubMed] [Google Scholar]
- Moulton A. W., Singer D. E., Haas J. S. Risk factors for stroke in patients with nonrheumatic atrial fibrillation: a case-control study. Am J Med. 1991 Aug;91(2):156–161. doi: 10.1016/0002-9343(91)90008-l. [DOI] [PubMed] [Google Scholar]
- Petersen P., Boysen G., Godtfredsen J., Andersen E. D., Andersen B. Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study. Lancet. 1989 Jan 28;1(8631):175–179. doi: 10.1016/s0140-6736(89)91200-2. [DOI] [PubMed] [Google Scholar]